Apoptotic signal transduction and T cell tolerance

Autoimmunity

Volumn 40, Issue 6, 2007, Pages 442-452

  Gatzka, Martina ^a   Walsh, Craig M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Apoptosis; Autoimmunity; Costimulation; T cell; Thymus; Tolerance

Indexed keywords

APOPTOSIS INDUCING FACTOR; BIM PROTEIN; CASPASE 10; CASPASE 3; CASPASE 6; CASPASE 7; CASPASE 8; CASPASE 9; CYTOCHROME C; ENDONUCLEASE G; FAS ANTIGEN; FAS ASSOCIATED DEATH DOMAIN PROTEIN; FAS LIGAND; FLICE INHIBITORY PROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN BAK; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN BID; PROTEIN KINASE ZAP 70; PROTEIN NOXA; PROTEIN P53; SECOND MITOCHONDRIAL ACTIVATOR OF CASPASE; SERINE PROTEINASE OMI; T LYMPHOCYTE RECEPTOR; TOLL LIKE RECEPTOR 3; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

APOPTOSIS; AUTOIMMUNE DISEASE; AUTOIMMUNE POLYENDOCRINOPATHY CANDIDIASIS ECTODERMAL DYSTROPHY; CELL DEATH; CLONAL ANERGY; DIABETES MELLITUS; ENZYME ACTIVATION; GENE MUTATION; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOPATHOGENESIS; IMMUNOREACTIVITY; LYMPHOPROLIFERATIVE DISEASE; MULTIPLE SCLEROSIS; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REGULATORY T LYMPHOCYTE; REVIEW; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; VIRUS IMMUNITY;

ANIMALS; APOPTOSIS; AUTOIMMUNITY; CLONAL DELETION; HUMANS; LYMPHOCYTE ACTIVATION; RECEPTORS, ANTIGEN, T-CELL; SELF TOLERANCE; SIGNAL TRANSDUCTION; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES; THYMUS GLAND;

EID: 34548306413     PISSN: 08916934     EISSN: 1607842X     Source Type: Journal    
DOI: 10.1080/08916930701464962     Document Type: Review

References (125)

1. Kerr, J., Wyllie, A. and Currie, A. (1972) Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer, 26, pp. 239-257.
2. Hildeman, DA, Zhu, Y., Mitchell, TC, Kappler, J. and Marrack, P. (2002) Molecular mechanisms of activated T cell death in vivo. Curr Opin Immunol, 14, pp. 354-359.
3. Chao, DT and Korsmeyer, SJ (1998) BCL-2 family: Regulators of cell death. Annu Rev Immunol, 16, pp. 395-419.
4. van Loo, G., Saelens, X., van Gurp, M., MacFarlane, M., Martin, SJ and Vandenabeele, P. (2002) The role of mitochondrial factors in apoptosis: A Russian roulette with more than one bullet. Cell Death Differ, 9, pp. 1031-1042.
5. Green, DR and Reed, JC (1998) Mitochondria and apoptosis. Science, 281, pp. 1309-1312.
6. Nijhawan, D., Budihardjo, I., Srinivasula, SM, Ahmad, M., Alnemri, ES and Wang, X. (1997) Cytochrome c and dATP-dependent formation of Apaf-1/ caspase-9 complex initiates an apoptotic protease cascade. Cell, 91, pp. 479-489.
7. Smith, K., Strasser, A. and Vaux, D. (1996) CrmA expression in T lymphocytes of transgenic mice inhibits CD95 Fas/APO-1-transduced apoptosis, but does not cause lymphadenopathy or autoimmune disease. EMBO J, 15, pp. 5167-5176.
8. Walsh, C., Wen, B., Chinnaiyan, A., O'Rourke, K., Dixit, V. and Hedrick, S. (1998) A role for FADD in T cell activation and development. Immunity, 8:4, pp. 439-449.
9. Dempsey, PW, Doyle, SE, He, JQ and Cheng, G. (2003) The signaling adaptors and pathways activated by TNF superfamily. Cytokine Growth Factor Rev, 14, pp. 193-209.
10. Medema, J., Scaffidi, C., Kischkel, F., Shevchenko, A., Mann, M., Krammer, P. and Peter, M. (1997) FLICE is activated by association with the CD95 death-inducing signaling complex (DISC). EMBO J, 16:10, pp. 2794-2804.
11. Walsh, CM, Luhrs, KA and Arechiga, AF (2003) The "fuzzy logic" of the death-inducing signaling complex in lymphocytes. J Clin Immunol, 23, pp. 333-353.
12. Yang, X., Chang, HY and Baltimore, D. (1998) Autoproteolytic activation of pro-caspases by oligomerization. Mol Cell, 1, pp. 319-325.
13. Muzio, M., Stockwell, BR, Stennicke, HR, Salvesen, GS and Dixit, VM (1998) An induced proximity model for caspase-8 activation. J Biol Chem, 273, pp. 2926-2930.
14. MacCorkle, RA, Freeman, KW and Spencer, DM (1998) Synthetic activation of caspases: Artificial death switches. Proc Natl Acad Sci USA, 95, pp. 3655-3660.
15. Siegel, RM (2006) Caspases at the crossroads of immune-cell life and death. Nat Rev Immunol, 6, pp. 308-317.
16. Dhein, J., Walczak, H., Baumler, C., Debatin, K. and Krammer, P. (1995) Autocrine T-cell suicide mediated by APO-1/(Fas/CD95). Nature, 373:6513, pp. 438-441.
17. Irmler, M., Thome, M., Hahne, M., Schneider, P., Hofmann, K., Steiner, V., Bodmer, JL, Schroter, M., Burns, K., Mattmann, C., Rimoldi, D., French, LE and Tschopp, J. (1997) Inhibition of death receptor signals by cellular FLIP. Nature, 388, pp. 190-195.
18. Panka, D., Cui, H., Ettinger, R., el-Khatib, M., Sherr, D., Stanger, B. and Marshak-Rothstein, A. (1995) Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature, 373:6513, pp. 444-448.
19. Brunner, T., Mogil, R., LaFace, D., Yoo, N., Mahboubi, A., Echeverri, F., Martin, S., Force, W., Lynch, D. and Ware, C. (1995) Cell-autonomous Fas CD95 /Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature, 373, pp. 441-444.
20. Scaffidi, C., Fulda, S., Srinivasan, A., Friesen, C., Tomaselli, KJ, Debatin, KM, Krammer, PH and Peter, ME (1998) Two CD95 (APO-1/Fas) signaling pathways. EMBO J, 17, pp. 1675-1687.
21. Sprick, MR and Walczak, H. (2004) The interplay between the Bcl-2 family and death receptor-mediated apoptosis. Biochim Biophys Acta, 1644, pp. 125-132.
22. Zhu, H., Xu, CJ and Yuan, J. (1998) Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell, 94, pp. 491-501.
23. Luo, X., Budihardjo, I., Zou, H., Slaughter, C. and Wang, X. (1998) Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell, 94, pp. 481-490.
24. Fang, M. and Wang, X. (2000) Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell, 102, pp. 33-42.
25. Suzuki, Y., Imai, Y., Nakayama, H., Takahashi, K., Takio, K. and Takahashi, R. (2001) A serine protease, HtrA2, is released from the mitochondria and interacts with XIAP, inducing cell death. Mol Cell, 8, pp. 613-621.
26. Zheng, L., Fisher, G., Miller, R., Peschon, J., Lynch, D. and Lenardo, M. (1995) Induction of apoptosis in mature T cells by tumour necrosis factor. Nature, 377:6547, pp. 348-351.
27. Holler, N., Zaru, R., Micheau, O., Thome, M., Attinger, A., Valitutti, S., Bodmer, JL, Schneider, P., Seed, B. and Tschopp, J. (2000) Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule. Nat Immunol, 1, pp. 489-495.
28. Denecker, G., Vercammen, D., Declercq, W. and Vandenabeele, P. (2001) Apoptotic and necrotic cell death induced by death domain receptors. Cell Mol Life Sci, 58, pp. 356-370.
29. Gupta, S. and Gollapudi, S. (2005) Molecular mechanisms of TNF-alpha-induced apoptosis in aging human T cell subsets. Int J Biochem Cell Biol, 37, pp. 1034-1042.
30. Janssen, EM, Droin, NM, Lemmens, EE, Pinkoski, MJ, Bensinger, SJ, Ehst, BD, Griffith, TS, Green, DR and Schoenberger, SP (2005) CD4+T-cell help controls CD8+T-cell memory via TRAIL-mediated activation-induced cell death. Nature, 434, pp. 88-93.
31. Voskoboinik, I., Smyth, MJ and Trapani, JA (2006) Perforin-mediated target-cell death and immune homeostasis. Nat Rev Immunol, 6, pp. 940-952.
32. Liu, N., Raja, SM, Zazzeroni, F., Metkar, SS, Shah, R., Zhang, M., Wang, Y., Bromme, D., Russin, WA, Lee, JC, Peter, ME, Froelich, CJ, Franzoso, G. and Ashton-Rickardt, PG (2003) NF-kappaB protects from the lysosomal pathway of cell death. EMBO J, 22, pp. 5313-5322.
33. Matloubian, M., Suresh, M., Glass, A., Galvan, M., Chow, K., Whitmire, JK, Walsh, CM, Clark, WR and Ahmed, R. (1999) A role for perforin in downregulating T-cell responses during chronic viral infection. J Virol, 73, pp. 2527-2536.
34. Stepp, SE, Dufourcq-Lagelouse, R., Deist, F Le, Bhawan, S., Certain, S., Mathew, PA, Henter, JI, Bennett, M., Fischer, A., Basile, G de Saint and Kumar, V. (1999) Perforin gene defects in familial hemophagocytic lymphohistiocytosis. Science, 286, pp. 1957-1959.
35. Liu, N., Phillips, T., Zhang, M., Wang, Y., Opferman, JT, Shah, R. and Ashton-Rickardt, PG (2004) Serine protease inhibitor 2A is a protective factor for memory T cell development. Nat Immunol, 5, pp. 919-926.
36. Zhang, M., Byrne, S., Liu, N., Wang, Y., Oxenius, A. and Ashton-Rickardt, PG (2007) Differential survival of cytotoxic T cells and memory cell precursors. J Immunol, 178, pp. 3483-3491.
37. Anderton, SM and Wraith, DC (2002) Selection and fine-tuning of the autoimmune T-cell repertoire. Nat Rev Immunol, 2, pp. 487-498.
38. Anderson, MS, Venanzi, ES, Klein, L., Chen, Z., Berzins, SP, Turley, SJ, von Boehmer, H., Bronson, R., Dierich, A., Benoist, C. and Mathis, D. (2002) Projection of an immunological self shadow within the thymus by the aire protein. Science, 298, pp. 1395-1401.
39. Liston, A., Lesage, S., Wilson, J., Peltonen, L. and Goodnow, CC (2003) Aire regulates negative selection of organ-specific T cells. Nat Immunol, 4, pp. 350-354.
40. Nagamine, K., Peterson, P., Scott, HS, Kudoh, J., Minoshima, S., Heino, M., Krohn, KJ, Lalioti, MD, Mullis, PE, Antonarakis, SE, Kawasaki, K., Asakawa, S., Ito, F. and Shimizu, N. (1997) Positional cloning of the APECED gene. Nat Genet, 17, pp. 393-398.
41. Ramsey, C., Winqvist, O., Puhakka, L., Halonen, M., Moro, A., Kampe, O., Eskelin, P., Pelto-Huikko, M. and Peltonen, L. (2002) Aire deficient mice develop multiple features of APECED phenotype and show altered immune response. Hum Mol Genet, 11, pp. 397-409.
42. Mathis, D. and Benoist, C. (2004) Back to central tolerance. Immunity, 20, pp. 509-516.
43. Marrack, P. and Kappler, J. (2004) Control of T cell viability. Annu Rev Immunol, 22, pp. 765-787.
44. Bunin, A., Khwaja, FW and Kersh, GJ (2005) Regulation of Bim by TCR signals in CD4/CD8 double-positive thymocytes. J Immunol, 175, pp. 1532-1539.
45. Harada, H., Quearry, B., Ruiz-Vela, A. and Korsmeyer, SJ (2004) Survival factor-induced extracellular signal-regulated kinase phosphorylates BIM, inhibiting its association with BAX and proapoptotic activity. Proc Natl Acad Sci USA, 101, pp. 15313-15317.
46. Cante-Barrett, K., Gallo, EM, Winslow, MM and Crabtree, GR (2006) Thymocyte negative selection is mediated by protein kinase C- and Ca2+ -dependent transcriptional induction of bim [corrected]. J Immunol, 176, pp. 2299-2306.
47. Bouillet, P., Purton, JF, Godfrey, DI, Zhang, LC, Coultas, L., Puthalakath, H., Pellegrini, M., Cory, S., Adams, JM and Strasser, A. (2002) BH3-only Bcl-2 family member Bim is required for apoptosis of autoreactive thymocytes. Nature, 415, pp. 922-926.
48. Rathmell, JC, Lindsten, T., Zong, WX, Cinalli, RM and Thompson, CB (2002) Deficiency in Bak and Bax perturbs thymic selection and lymphoid homeostasis. Nat Immunol, 3, pp. 932-939.
49. Strasser, A., Harris, AW, von Boehmer, H. and Cory, S. (1994) Positive and negative selection of T cells in T-cell receptor transgenic mice expressing a bcl-2 transgene. Proc Natl Acad Sci USA, 91, pp. 1376-1380.
50. Linette, GP, Grusby, MJ, Hedrick, SM, Hansen, TH, Glimcher, LH and Korsmeyer, SJ (1994) Bcl-2 is upregulated at the CD4+ CD8+ stage during positive selection and promotes thymocyte differentiation at several control points. Immunity, 1, pp. 197-205.
51. Pena, JC, Chang, B., Margosian, E., Davidson, L., Alt, FW and Thompson, CB (1995) Bclx regulates the survival of double-positive thymocytes. Proc Natl Acad Sci USA, 92, pp. 4763-4767.
52. Chao, DT and Korsmeyer, SJ (1997) BCL-XL-regulated apoptosis in T cell development. Int Immunol, 9, pp. 1375-1384.
53. Grillot, DA, Merino, R. and Nunez, G. (1995) Bcl-XL displays restricted distribution during T cell development and inhibits multiple forms of apoptosis but not clonal deletion in transgenic mice. J Exp Med, 182, pp. 1973-1983.
54. Page, D., Roberts, E., Peschon, J. and Hedrick, S. (1998) TNF receptor-deficient mice reveal striking differences between several models of thymocyte negative selection. J Immunol, 160, pp. 120-133.
55. Zhou, T., Bluethmann, H., Eldridge, J., Brockhaus, M., Berry, K. and Mountz, J. (1991) Abnormal thymocyte development and production of autoreactive T cells in T cell receptor transgenic autoimmune mice. J Immunol, 147:2, pp. 466-474.
56. Castro, J., Listman, J., Jacobson, B., Wang, Y., Lopez, P., Ju, JS, Finn, P. and Perkins, D. (1996) Fas modulation of apoptosis during negative selection of thymocytes. Immunity, 5, pp. 617-627.
57. Kishimoto, H. and Sprent, J. (1997) Negative selection in the thymus includes semimature T cells. J Exp Med, 185:2, pp. 263-271.
58. Lamhamedi-Cherradi, SE, Zheng, SJ, Maguschak, KA, Peschon, J. and Chen, YH (2003) Defective thymocyte apoptosis and accelerated autoimmune diseases in TRAIL -/- mice. Nat Immunol, 4, pp. 255-260.
59. Green, DR (2003) The suicide in the thymus, a twisted trail. Nat Immunol, 4, pp. 207-208.
60. Cretney, E., Uldrich, AP, Berzins, SP, Strasser, A., Godfrey, DI and Smyth, MJ (2003) Normal thymocyte negative selection in TRAIL-deficient mice. J Exp Med, 198, pp. 491-496.
61. Yue, HH, Diehl, GE and Winoto, A. (2005) Loss of TRAIL-R does not affect thymic or intestinal tumor development in p53 and adenomatous polyposis coli mutant mice. Cell Death Differ, 12, pp. 94-97.
62. Doerfler, P., Forbush, KA and Perlmutter, RM (2000) Caspase enzyme activity is not essential for apoptosis during thymocyte development. J Immunol, 164, pp. 4071-4079.
63. Woronicz, JD, Calnan, B., Ngo, V. and Winoto, A. (1994) Requirement for the orphan steroid receptor Nur77 in apoptosis of T-cell hybridomas. Nature, 367, pp. 277-281.
64. Calnan, BJ, Szychowski, S., Chan, FK, Cado, D. and Winoto, A. (1995) A role for the orphan steroid receptor Nur77 in apoptosis accompanying antigen-induced negative selection. Immunity, 3, pp. 273-282.
65. Cheng, LE, Chan, FK, Cado, D. and Winoto, A. (1997) Functional redundancy of the Nur77 and Nor-1 orphan steroid receptors in T-cell apoptosis. EMBO J, 16, pp. 1865-1875.
66. Sun, Z., Unutmaz, D., Zou, YR, Sunshine, MJ, Pierani, A., Brenner-Morton, S., Mebius, RE and Littman, DR (2000) Requirement for RORgamma in thymocyte survival and lymphoid organ development. Science, 288, pp. 2369-2373.
67. Hogquist, K., Jameson, S., Heath, W., Howard, J., Bevan, M. and Carbone, F. (1994) T cell receptor antagonist peptides induce positive selection. Cell, 76, pp. 17-27.
68. Hogquist, K., Jameson, S. and Bevan, M. (1995) Strong agonist ligands for the T cell receptor do not mediate positive selection of functional CD8+T cells. Immunity, 3, pp. 79-86.
69. Alberola-Ila, J., Hogquist, K., Swan, K., Bevan, M. and Perlmutter, R. (1996) Positive and negative selection invoke distinct signaling pathways. J Exp Med, 184:1
70. Yablonski, D. and Weiss, A. (2001) Mechanisms of signaling by the hematopoietic-specific adaptor proteins, SLP-76 and LAT and their B cell counterpart, BLNK/SLP-65. Adv Immunol, 79, pp. 93-128.
71. Bromley, SK, Burack, WR, Johnson, KG, Somersalo, K., Sims, TN, Sumen, C., Davis, MM, Shaw, AS, Allen, PM and Dustin, ML (2001) The immunological synapse. Annu Rev Immunol, 19, pp. 375-396.
72. Sharpe, AH and Freeman, GJ (2002) The B7-CD28 superfamily. Nat Rev Immunol, 2, pp. 116-126.
73. Diehn, M., Alizadeh, AA, Rando, OJ, Liu, CL, Stankunas, K., Botstein, D., Crabtree, GR and Brown, PO (2002) Genomic expression programs and the integration of the CD28 costimulatory signal in T cell activation. Proc Natl Acad Sci USA, 99, pp. 11796-11801.
74. Michel, F., Attal-Bonnefoy, G., Mangino, G., Mise-Omata, S. and Acuto, O. (2001) CD28 as a molecular amplifier extending TCR ligation and signaling capabilities. Immunity, 15, pp. 935-945.
75. Croft, M. (2003) Co-stimulatory members of the TNFR family: Keys to effective T-cell immunity?. Nat Rev Immunol, 3, pp. 609-620.
76. Song, J., Salek-Ardakani, S., Rogers, PR, Cheng, M., Van Parijs, L. and Croft, M. (2004) The costimulation-regulated duration of PKB activation controls T cell longevity. Nat Immunol
77. Salek-Ardakani, S. and Croft, M. (2006) Regulation of CD4 T cell memory by OX40 (CD134). Vaccine, 24, pp. 872-883.
78. Redmond, WL and Sherman, LA (2005) Peripheral tolerance of CD8 T lymphocytes. Immunity, 22, pp. 275-284.
79. Heissmeyer, V. and Rao, A. (2004) E3 ligases in T cell anergy-turning immune responses into tolerance. Sci STKE, 2004, p. pe29.
80. Waterhouse, P., Penninger, JM, Timms, E., Wakeham, A., Shahinian, A., Lee, KP, Thompson, CB, Griesser, H. and Mak, TW (1995) Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Science, 270, pp. 985-988.
81. Chen, W., Jin, W., Tian, H., Sicurello, P., Frank, M., Orenstein, JM and Wahl, SM (2001) Requirement for transforming growth factor beta1 in controlling T cell apoptosis. J Exp Med, 194, pp. 439-453.
82. Green, DR, Droin, N. and Pinkoski, M. (2003) Activation-induced cell death in T cells. Immunol Rev, 193, pp. 70-81.
83. Kishimoto, H. and Sprent, J. (1999) Strong TCR ligation without costimulation causes rapid onset of Fas-dependent apoptosis of naive murine CD4+T cells. J Immunol, 163, pp. 1817-1826.
84. Mixter, PF, Russell, JQ and Budd, RC (1994) Delayed kinetics of T lymphocyte anergy and deletion in lpr mice. J Autoimmun, 7, pp. 697-710.
85. Russell, JH, Rush, B., Weaver, C. and Wang, R. (1993) Mature T cells of autoimmune lpr/lpr mice have a defect in antigen-stimulated suicide. Proc Natl Acad Sci USA, 90, pp. 4409-4413.
86. Russell, JH and Wang, R. (1993) Autoimmune gld mutation uncouples suicide and cytokine/proliferation pathways in activated, mature T cells. Eur J Immunol, 23, pp. 2379-2382.
87. Singer, G. and Abbas, A. (1994) The fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice. Immunity, 1, pp. 365-371.
88. Mogil, RJ, Radvanyi, L., Gonzalez-Quintial, R., Miller, R., Mills, G., Theofilopoulos, AN and Green, DR (1995) Fas (CD95) participates in peripheral T cell deletion and associated apoptosis in vivo. Int Immunol, 7, pp. 1451-1458.
89. Suvannavejh, GC, Canto, MC Dal, Matis, LA and Miller, SD (2000) Fas-mediated apoptosis in clinical remissions of relapsing experimental autoimmune encephalomyelitis. J Clin Invest, 105, pp. 223-231.
90. Kerstan, A. and Hunig, T. (2004) Cutting edge: Distinct TCR- and CD28-derived signals regulate CD95L, Bcl-xL, and the survival of primary T cells. J Immunol, 172, pp. 1341-1345.
91. Watanabe-Fukunaga, R., Brannan, C., Copeland, N., Jenkins, N. and Nagata, S. (1992) Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature, 356:6367, pp. 314-317.
92. Takahashi, T., Tanaka, M., Brannan, C., Jenkins, N., Copeland, N., Suda, T. and Nagata, S. (1994) Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell, 76:6, pp. 969-976.
93. Theofilopoulos, AN, Balderas, RS, Hang, L. and Dixon, FJ (1983) Monoclonal IgM rheumatoid factors derived from arthritic MRL/Mp-lpr/lpr mice. J Exp Med, 158, pp. 901-919.
94. Lenardo, MJ (2003) Molecular regulation of T lymphocyte homeostasis in the healthy and diseased immune system. Immunol Res, 27, pp. 387-398.
95. Lenardo, MJ (1991) Interleukin-2 programs mouse alpha beta T lymphocytes for apoptosis. Nature, 353, pp. 858-861.
96. Thome, M. and Tschopp, J. (2001) Regulation of lymphocyte proliferation and death by FLIP. Nat Rev Immunol, 1, pp. 50-58.
97. Semra, YK, Seidi, OA and Sharief, MK (2001) Overexpression of the apoptosis inhibitor FLIP in T cells correlates with disease activity in multiple sclerosis. J Neuroimmunol, 113, pp. 268-274.
98. Hao, Z., Hampel, B., Yagita, H. and Rajewsky, K. (2004) T cell-specific ablation of Fas leads to Fas ligand-mediated lymphocyte depletion and inflammatory pulmonary fibrosis. J Exp Med, 199, pp. 1355-1365.
99. Sytwu, H., Liblau, R. and McDevitt, H. (1996) The roles of Fas/APO-1 (CD95) and TNF in antigen-induced programmed cell death in T cell receptor transgenic mice. Immunity, 5:1, pp. 17-30.
100. Nguyen, LT, McKall-Faienza, K., Zakarian, A., Speiser, DE, Mak, TW and Ohashi, PS (2000) TNF receptor 1 (TNFR1) and CD95 are not required for T cell deletion after virus infection but contribute to peptide-induced deletion under limited conditions. Eur J Immunol, 30, pp. 683-688.
101. Mariani, SM and Krammer, PH (1998) Surface expression of TRAIL/Apo-2 ligand in activated mouse T and B cells. Eur J Immunol, 28, pp. 1492-1498.
102. Jeremias, I., Herr, I., Boehler, T. and Debatin, KM (1998) TRAIL/ Apo-2-ligand-induced apoptosis in human T cells. Eur J Immunol, 28, pp. 143-152.
103. Song, K., Chen, Y., Goke, R., Wilmen, A., Seidel, C., Goke, A. and Hilliard, B. (2000) Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is an inhibitor of autoimmune inflammation and cell cycle progression. J Exp Med, 191, pp. 1095-1104.
104. White, J., Herman, A., Pullen, A., Kubo, R., Kappler, J. and Marrack, P. (1989) The V beta-specific superantigen staphylococcal enterotoxin B: Stimulation of mature T cells and clonal deletion in neonatal mice. Cell, 56, pp. 27-35.
105. Hildeman, DA, Zhu, Y., Mitchell, TC, Bouillet, P., Strasser, A., Kappler, J. and Marrack, P. (2002) Activated T cell death in vivo mediated by proapoptotic bcl-2 family member bim. Immunity, 16, pp. 759-767.
106. Davey, GM, Kurts, C., Miller, JF, Bouillet, P., Strasser, A., Brooks, AG, Carbone, FR and Heath, WR (2002) Peripheral deletion of autoreactive CD8 T cells by cross presentation of self-antigen occurs by a Bcl-2-inhibitable pathway mediated by Bim. J Exp Med, 196, pp. 947-955.
107. Lowe, SW, Schmitt, EM, Smith, SW, Osborne, BA and Jacks, T. (1993) p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature, 362, pp. 847-849.
108. Oda, E., Ohki, R., Murasawa, H., Nemoto, J., Shibue, T., Yamashita, T., Tokino, T., Taniguchi, T. and Tanaka, N. (2000) Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis. Science, 288, pp. 1053-1058.
109. Nakano, K. and Vousden, KH (2001) PUMA a novel proapoptotic gene, is induced by p53. Mol Cell, 7, pp. 683-694.
110. Bauer, A., Villunger, A., Labi, V., Fischer, SF, Strasser, A., Wagner, H., Schmid, RM and Hacker, G. (2006) The NF-kappaB regulator Bcl-3 and the BH3-only proteins Bim and Puma control the death of activated T cells. Proc Natl Acad Sci USA, 103, pp. 10979-10984.
111. Matzinger, P. (2002) The danger model: A renewed sense of self. Science, 296, pp. 301-305.
112. Mitchell, TC, Hildeman, D., Kedl, RM, Teague, TK, Schaefer, BC, White, J., Zhu, Y., Kappler, J. and Marrack, P. (2001) Immunological adjuvants promote activated T cell survival via induction of Bcl-3. Nat Immunol, 2, pp. 397-402.
113. Gelman, AE, Zhang, J., Choi, Y. and Turka, LA (2004) Toll-like receptor ligands directly promote activated CD4+T cell survival. J Immunol, 172, pp. 6065-6073.
114. Wraith, DC, Nicolson, KS and Whitley, NT (2004) Regulatory CD4+T cells and the control of autoimmune disease. Curr Opin Immunol, 16, pp. 695-701.
115. Burchill, MA, Goetz, CA, Prlic, M., O'Neil, JJ, Harmon, IR, Bensinger, SJ, Turka, LA, Brennan, P., Jameson, SC and Farrar, MA (2003) Distinct effects of STAT5 activation on CD4+ and CD8+ T cell homeostasis: Development of CD4+CD25+ regulatory T cells versus CD8+ memory T cells. J Immunol, 171, pp. 5853-5864.
116. Malek, TR and Bayer, AL (2004) Tolerance, not immunity, crucially depends on IL-2. Nat Rev Immunol, 4, pp. 665-674.
117. Nelson, BH and Willerford, DM (1998) Biology of the interleukin-2 receptor. Adv Immunol, 70, pp. 1-81.
118. Van Parijs, L., Biuckians, A., Ibragimov, A., Alt, FW, Willerford, DM and Abbas, AK (1997) Functional responses and apoptosis of CD25 (IL-2R alpha)-deficient T cells expressing a transgenic antigen receptor. J Immunol, 158, pp. 3738-3745.
119. Refaeli, Y., Van Parijs, L., London, CA, Tschopp, J. and Abbas, AK (1998) Biochemical mechanisms of IL-2-regulated Fas-mediated T cell apoptosis. Immunity, 8, pp. 615-623.
120. Malek, TR (2003) The main function of IL-2 is to promote the development of T regulatory cells. J Leukoc Biol, 74, pp. 961-965.
121. Snow, JW, Abraham, N., Ma, MC, Herndier, BG, Pastuszak, AW and Goldsmith, MA (2003) Loss of tolerance and autoimmunity affecting multiple organs in STAT5A/5B-deficient mice. J Immunol, 171, pp. 5042-5050.
122. Krysko, DV, D'Herde, K. and Vandenabeele, P. (2006) Clearance of apoptotic and necrotic cells and its immunological consequences. Apoptosis, 11, pp. 1709-1726.
123. Kroemer, G. and Jaattela, M. (2005) Lysosomes and autophagy in cell death control. Nat Rev Cancer, 5, pp. 886-897.
124. Ferguson, TA, Green, DR and Griffith, TS (2002) Cell death and immune privilege. Int Rev Immunol, 21, pp. 153-172.
125. Viorritto, IC, Nikolov, NP and Siegel, RM (2007) Autoimmunity versus tolerance: Can dying cells tip the balance?. Clin Immunol, 122, pp. 125-134.